We are live on ! Find out more
MTACU

MedTech Acquisition Corporation Unit
MTACU

Delisted

MTACU was delisted on the 10th of August, 2023.

Back to rankings

5 hedge funds and large institutions have $474K invested in MedTech Acquisition Corporation Unit in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% less funds holding

Funds holding: 11 → 5 (-6)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

99% less capital invested

Capital invested by funds: $40.7M → $474K (-$40.2M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-6
Holders Change %
-54.55%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ICMH
Integrity Capital Management (HK)
Hong Kong
+$46.7K
2
DM
Deerfield Management
New York
+$10

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$18.5M
2
MP
MSD Partners
New York
-$12M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$3.11M
4
BCL
Bracebridge Capital LLC
Massachusetts
-$2.98M
5
ZCA
Zeke Capital Advisors
Pennsylvania
-$2.01M

MTACU Hedge Fund Activity: Q1 2022 in Review

5 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q1 2022, worth a combined $474K — down 99% from $40.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MTACU and 2 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Integrity Capital Management (HK), opening a new position worth an estimated $46.7K. The largest seller was Wellington Management Group, exiting entirely with an estimated $18.5M sold.

  • 5 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q1 2022, down from 11 in Q4 2021.
  • Funds reported $474K of MedTech Acquisition Corporation Unit stock for Q1 2022, down 99% quarter-over-quarter.
  • 2 funds opened new MedTech Acquisition Corporation Unit positions in Q1 2022 and 8 closed out, a net change of -6 holders.
  • The largest MedTech Acquisition Corporation Unit buyer in Q1 2022 was Integrity Capital Management (HK), an estimated $46.7K added.
  • The largest MedTech Acquisition Corporation Unit seller in Q1 2022 was Wellington Management Group, an estimated $18.5M sold.

Based on aggregated 13F filings for Q1 2022.